カテゴリー： 世界, 医療/バイオ, Market Research Future

世界のCBD（カンナビジオール）市場（〜2030年）

【英語タイトル】Global CBD Market Research Report Forecast to 2030

Market Research Futureが出版した調査資料（MRF23JUN003）・商品コード：MRF23JUN003
・発行会社（調査会社）：Market Research Future
・発行日：2023年4月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（印刷不可、Online Access）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Enterprisewide Price（印刷可）USD7,250 ⇒換算￥1,102,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Market Research Future社の本調査レポートは、CBD（カンナビジオール）の世界市場について総合的に分析し、今後の市場動向を予測した資料です。本書は、エグゼクティブサマリー、イントロダクション、調査手法、市場動向、市場要因分析、形態別（固体、液体）分析、投与経路別（チンキ剤、カプセル、吸入、エアロゾール）分析、製品別（食品用、治療用）分析、用途別（神経再生障害、線維筋痛症、糖尿病、プロテインバー、エナジードリンク）分析、地域別（南北アメリカ、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争状況、企業情報などの項目を掲載しています。なお、主要企業として、Folium Biosciences、Aphria Inc.、Elixinol Global Limited LLC.、Green Roads of Florida、Freedom Leaf Inc、CBD Health Solutions、CV Sciences、Isodiol International Inc、Canopy Growth Corporationなどの情報が含まれています。
・エグゼクティブサマリー
・イントロダクション
・調査手法
・市場動向
・市場要因分析
・世界のCBD（カンナビジオール）市場規模：形態別
- 固体型CBD（カンナビジオール）の市場規模
- 液体型CBD（カンナビジオール）の市場規模
・世界のCBD（カンナビジオール）市場規模：投与経路別
- チンキ剤における市場規模
- カプセルにおける市場規模
- 吸入における市場規模
- エアロゾールにおける市場規模
・世界のCBD（カンナビジオール）市場規模：製品別
- 食品用CBD（カンナビジオール）の市場規模
- 治療用CBD（カンナビジオール）の市場規模
・世界のCBD（カンナビジオール）市場規模：用途別
- 神経再生障害における市場規模
- 線維筋痛症における市場規模
- 糖尿病における市場規模
- プロテインバーにおける市場規模
- エナジードリンクにおける市場規模
・世界のCBD（カンナビジオール）市場規模：地域別
- 南北アメリカのCBD（カンナビジオール）市場規模
- ヨーロッパのCBD（カンナビジオール）市場規模
- アジア太平洋のCBD（カンナビジオール）市場規模
- 中東・アフリカのCBD（カンナビジオール）市場規模
・競争状況
・企業情報

CBD（カンナビジオール）の2030年までの市場予測

市場概要：
麻植物には、非中毒性物質であるCBD（カンナビジオール）が含まれています。この化合物は、テトラヒドロカンナビノール（THC）よりも高濃度で大麻に含まれています。この業界には、さまざまな形態（固体、液体）、投与経路（チンキ剤、カプセル、吸入（煙または蒸気）、エアゾールスプレー）、製品（食品グレード、治療グレード）があります。
精神作用のないCBD（カンナビジオール）は、カンナビノイドの中で最も広く消費されています。不安、うつ、ストレス、糖尿病、痛み、がん症状、炎症など、さまざまな症状の治療に効果があることがわかっています。そのため、CBD（カンナビジオール）オイルの需要が高まり、世界市場が大きく成長しました。これは、CBD（カンナビジオール）オイルが高い利益率を提供するため、商業小売業者にCBD（カンナビジオール）オイルへの投資を促しました。CVS Health、Rite Aid、Walgreens Boots Allianceなどのウェルネスと健康の小売業者は、CBD（カンナビジオール）オイルを含む製品を提供し始めています。

セグメント概要：
世界市場は、形態、製品、投与経路、用途、エンドユーザー、地域セグメントに分別されています。世界のCBD（カンナビジオール）市場は固形と液体に分けられます。投与経路を考慮すると、CBD（カンナビジオール）の世界市場はチンキ剤、カプセル、吸入、エアゾールスプレーに分けられます。製品タイプによって、世界市場は治療グレードと食品グレードに分けられます。アプリケーションに基づいて、世界のCBD（カンナビジオール）市場は線維筋痛症、糖尿病、プロテインバー、神経再生障害、エネルギードリンクに細分化されます。エンドユーザーセグメントは、食品＆飲料とヘルスケアをカバーし、ソースセグメントには有機と無機が含まれます。

地域分析：
世界のCBD（カンナビジオール）市場は、北米、ヨーロッパ、アジア太平洋、その他の地域に集中しています。2021年は南北アメリカが最大のCBD（カンナビジオール）市場地域でした。WHOによると、世界中で約147百万人がマリファナやその他のカンナビス関連製品を使用しています。さらに、カンナビスベースの製品を使用する22.2百万人のアメリカ人は12歳以上です。ヨーロッパは、CBD（カンナビジオール）の地域市場で2番目に大きな地位を占めています。CBD（カンナビジオール）の使用はヨーロッパ市場で合法です。農務省、ブルガリア食品安全庁、農務省はすべてヨーロッパでのCBD（カンナビジオール）の使用を承認しています。これらの機関はCBD（カンナビジオール）製品の「自由販売証明書」を発行しています。これらの合法化と承認がヨーロッパ市場の成長を後押ししています。ヨーロッパでは合法ですが、積極的な制限もあります。また、大麻に関する法律はヨーロッパ各国で異なります。市場に参加する様々な企業が様々な機会と発展の余地を生み出しています。

主要企業：
この市場調査における主要企業には、Folium Biosciences, Aphria Inc., Elixinol Global Limited, LLC., Green Roads of Florida, Freedom Leaf Inc, CBD（カンナビジオール） Health Solutions, CV Sciences, Isodiol International Inc, Canopy Growth Corporation and Medical Marijuana Inc.などが含まれます。

新型コロナウイルスの影響：
新型コロナウイルスの蔓延は、世界中の産業界に異常な閉鎖を引き起こし、日常業務の多くを混乱させ、破壊しました。このため小売店の閉店が相次ぎ、世界市場のサプライチェーンが不足する事態に陥っています。この混乱の主な原因は、中国やインドなどの原材料生産国の操業停止です。さらに、アメリカにおけるCBD（カンナビジオール）ベースの製品のサプライチェーンと生産は、他の原料供給の混乱によって深刻な影響を受けています。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION 17
2.2 SCOPE OF THE STUDY 17
2.3 MARKET STRUCTURE 18
3 RESEARCH METHODOLOGY
3.1 RESEARCH METHODOLOGY 19
3.2 PRIMARY RESEARCH 20
3.3 SECONDARY RESEARCH 21
3.4 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.5 FORECAST MODEL 22
4 MARKET DYNAMICS
4.1 INTRODUCTION 23
4.2 DRIVERS 24
4.2.1 GROWING RESEARCH AND DEVELOPMENT ACTIVITIES AND FINANCIAL SUPPORT BY VARIOUS PRIVATE AND
GOVERNMENT ORGANIZATIONS FOR CANNABINOID RESEARCH 24
4.2.2 RISING OCCURRENCE OF CHRONIC DISEASES AND RELATED COMPLICATIONS 24
4.2.3 LEGALIZATION OF CANNABINOID (CBD) IN VARIOUS REGIONS 24
4.3 RESTRAINTS 25
4.3.1 ADVERSE EFFECTS ASSOCIATED WITH CANNABIS 25
4.3.2 STRINGENT GOVERNMENT POLICIES 25
4.4 OPPORTUNITIES 25
4.4.1 IMPROVING STATUS OF CANNABIS IN ASIAN COUNTRIES 25
4.5 MEGATRENDS AND TECHNOLOGICAL ADVANCEMENTS 26
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 27
5.1.1 RESEARCH & DEVELOPMENT 27
5.1.2 MANUFACTURING 27
5.1.3 DISTRIBUTION AND SALES 28
5.1.4 POST-SALES MONITORING 28
5.2 PORTER’S FIVE FORCES MODEL 29
5.2.1 THREAT OF NEW ENTRANTS 29
5.2.2 BARGAINING POWER OF SUPPLIERS 30
5.2.3 BARGAINING POWER OF BUYERS 30
5.2.4 THREAT OF SUBSTITUTES 30
5.2.5 INTENSITY OF RIVALRY 30
5.3 ETOP ANALYSIS 31
5.3.1 THREAT 31
5.3.1.1 STRINGENT REGULATORY SCENARIO 31
5.3.2 OPPORTUNITIES 31
5.3.2.1 EXPLORING NEW APPLICATIONS 31
5.4 INVESTMENT OPPORTUNITY ANALYSIS 31
5.5 PRICING ANALYSIS 32
5.6 REGULATORY SCENARIO 32
6 CBD MARKET, BY FORM
6.1 INTRODUCTION 33
6.2 SOLID 34
6.3 LIQUID 34
7 CBD MARKET, BY ROUTES OF ADMINISTRATION
7.1 INTRODUCTION 35
7.2 TINCTURE 36
7.3 CAPSULES 36
7.4 INHALATION (SMOKE OR VAPOR) 37
7.5 AEROSOL SPRAY 37
8 CBD MARKET, BY PRODUCT
8.1 INTRODUCTION 38
8.2 FOOD GRADE 39
8.3 THERAPEUTIC GRADE 39
9 CBD MARKET, BY APPLICATION
9.1 INTRODUCTION 40
9.2 NEUROGENERATIVE DISORDER 41
9.3 FIBROMYALGIA 41
9.4 DIABETES 42
9.5 PROTEIN BARS 42
9.6 ENERGY DRINKS 42
10 CBD MARKET, BY END USE
10.1 INTRODUCTION 43
10.2 FOOD & BEVERAGE 44
10.3 HEALTHCARE 44
11 CBD MARKET, BY SOURCE
11.1 INTRODUCTION 45
11.2 ORGANIC 46
11.3 INORGANIC 46
12 GLOBAL CBD MARKET, BY REGION
12.1 INTRODUCTION 47
12.2 AMERICAS 49
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1 NORTH AMERICA 51
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1.1 US 53
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1.2 CANADA 55
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2 LATIN AMERICA 57
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2.1 BRAZIL 59
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2.2 REST OF LATIN AMERICA 61
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3 EUROPE 64
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1 WESTERN EUROPE 66
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.1 FRANCE 68
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.2 ITALY 70
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.3 GERMANY 72
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.4 UK 74
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.5 REST OF WESTERN EUROPE 76
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.2 EASTERN EUROPE 78
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4 ASIA-PACIFIC 81
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.1 JAPAN 83
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.2 CHINA 85
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.3 INDIA 87
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.4 REST OF ASIA-PACIFIC 89
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.5 MIDDLE EAST & AFRICA 91
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
13 COMPETITIVE LANDSCAPE
13.1 COMPETITIVE LANDSCAPE 94
14 COMPANY PROFILES
14.1 APHRIA INC. 97
14.1.1 COMPANY OVERVIEW 97
14.1.2 FINANCIAL OVERVIEW 97
14.1.3 PRODUCTS/SERVICES OFFERED 98
14.1.4 KEY DEVELOPMENTS 98
14.1.5 SWOT ANALYSIS 98
14.1.6 KEY STRATEGIES 99
14.2 FOLIUM BIOSCIENCES 100
14.2.1 COMPANY OVERVIEW 100
14.2.2 FINANCIAL OVERVIEW 100
14.2.3 PRODUCTS/SERVICES OFFERED 101
14.2.4 KEY DEVELOPMENTS 101
14.2.5 SWOT ANALYSIS 102
14.2.6 KEY STRATEGIES 102
14.3 FREEDOM LEAF, INC. 103
14.3.1 COMPANY OVERVIEW 103
14.3.2 FINANCIAL OVERVIEW 103
14.3.3 PRODUCTS/SERVICES OFFERED 103
14.3.4 KEY DEVELOPMENTS 104
14.3.5 SWOT ANALYSIS 104
14.3.6 KEY STRATEGIES 104
14.4 GREEN ROADS OF FLORIDA, LLC 105
14.4.1 COMPANY OVERVIEW 105
14.4.2 FINANCIAL OVERVIEW 105
14.4.3 PRODUCTS/SERVICES OFFERED 105
14.4.4 KEY DEVELOPMENTS 105
14.4.5 SWOT ANALYSIS 106
14.4.6 KEY STRATEGIES 106
14.5 CBD HEALTH SOLUTIONS, LLC 107
14.5.1 COMPANY OVERVIEW 107
14.5.2 FINANCIAL OVERVIEW 107
14.5.3 PRODUCTS/SERVICES OFFERED 107
14.5.4 KEY DEVELOPMENTS 107
14.5.5 SWOT ANALYSIS 108
14.5.6 KEY STRATEGIES 108
14.6 ENDOCA 109
14.6.1 COMPANY OVERVIEW 109
14.6.2 FINANCIAL OVERVIEW 109
14.6.3 PRODUCTS/SERVICES OFFERED 110
14.6.4 KEY DEVELOPMENTS 110
14.6.5 SWOT ANALYSIS 111
14.6.6 KEY STRATEGIES 111
14.7 ISODIOL INTERNATIONAL INC. 112
14.7.1 COMPANY OVERVIEW 112
14.7.2 FINANCIAL OVERVIEW 112
14.7.3 PRODUCTS/SERVICES OFFERED 112
14.7.4 KEY DEVELOPMENTS 113
14.7.5 SWOT ANALYSIS 113
14.7.6 KEY STRATEGIES 113
14.8 CV SCIENCES, INC. 114
14.8.1 COMPANY OVERVIEW 114
14.8.2 FINANCIAL OVERVIEW 114
14.8.3 PRODUCTS/SERVICES OFFERED 114
14.8.4 KEY DEVELOPMENTS 115
14.8.5 SWOT ANALYSIS 115
14.8.6 KEY STRATEGIES 115
14.9 MEDICAL MARIJUANA, INC. 116
14.9.1 COMPANY OVERVIEW 116
14.9.2 FINANCIAL OVERVIEW 116
14.9.3 PRODUCTS/SERVICES OFFERED 117
14.9.4 KEY DEVELOPMENTS 117
14.9.5 SWOT ANALYSIS 118
14.9.6 KEY STRATEGIES 118
14.10 CANOPY GROWTH CORPORATION 119
14.10.1 COMPANY OVERVIEW 119
14.10.2 FINANCIAL OVERVIEW 119
14.10.3 PRODUCTS/SERVICES OFFERED 119
14.10.4 KEY DEVELOPMENTS 120
14.10.5 SWOT ANALYSIS 120
14.10.6 KEY STRATEGIES 120
14.11 ELIXINOL GLOBAL LIMITED 121
14.11.1 COMPANY OVERVIEW 121
14.11.2 FINANCIAL OVERVIEW 121
14.11.3 PRODUCTS/SERVICES OFFERED 122
14.11.4 KEY DEVELOPMENTS 122
14.11.5 SWOT ANALYSIS 122
14.11.6 KEY STRATEGIES 122
15 APPENDIX
15.1 REFERENCES 123
15.2 RELATED REPORTS 123

LIST OF TABLES
TABLE 1 MARKET SYNOPSIS 16
TABLE 2 PRIMARY INTERVIEWS 20
TABLE 3 GLOBAL CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 33
TABLE 4 GLOBAL CANNABIDIOL (CBD) MARKET, FOR SOLID, BY REGION 2019–2030 (USD MILLION) 34
TABLE 5 GLOBAL FOR LIQUID, BY REGION 2019–2030 (USD MILLION) 34
TABLE 6 GLOBAL CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 35
TABLE 7 GLOBAL CANNABIDIOL (CBD) MARKET, FOR TINCTURE, BY REGION 2019–2030 (USD MILLION) 36
TABLE 8 GLOBAL FOR CAPSULES, BY REGION 2019–2030 (USD MILLION) 36
TABLE 9 GLOBAL FOR INHALATION (SMOKE OR VAPOR), BY REGION 2019–2030 (USD MILLION) 37
TABLE 10 GLOBAL FOR AEROSOL SPRAY, BY REGION 2019–2030 (USD MILLION) 37
TABLE 11 GLOBAL CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 38
TABLE 12 GLOBAL CANNABIDIOL (CBD) MARKET, FOR FOOD GRADE, BY REGION 2019–2030 (USD MILLION) 39
TABLE 13 GLOBAL FOR THERAPEUTIC GRADE, BY REGION 2019–2030 (USD MILLION) 39
TABLE 14 GLOBAL CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 40
TABLE 15 GLOBAL CANNABIDIOL (CBD) MARKET, FOR NEUROGENERATIVE DISORDER, BY REGION 2019–2030 (USD MILLION) 41
TABLE 16 GLOBAL FOR FIBROMYALGIA, BY REGION 2019–2030 (USD MILLION) 41
TABLE 17 GLOBAL FOR DIABETES, BY REGION 2019–2030 (USD MILLION) 42
TABLE 18 GLOBAL FOR PROTEIN BARS, BY REGION 2019–2030 (USD MILLION) 42
TABLE 19 GLOBAL FOR ENERGY DRINKS, BY REGION 2019–2030 (USD MILLION) 42
TABLE 20 GLOBAL CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 43
TABLE 21 GLOBAL CANNABIDIOL (CBD) MARKET, FOR FOOD & BEVERAGE, BY REGION 2019–2030 (USD MILLION) 44
TABLE 22 GLOBAL FOR HEALTHCARE, BY REGION 2019–2030 (USD MILLION) 44
TABLE 23 GLOBAL CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 45
TABLE 24 GLOBAL CANNABIDIOL (CBD) MARKET, FOR ORGANIC, BY REGION 2019–2030 (USD MILLION) 46
TABLE 25 GLOBAL FOR INORGANIC, BY REGION 2019–2030 (USD MILLION) 46
TABLE 26 GLOBAL CANNABIDIOL (CBD) MARKET, BY REGION 2019–2030 (USD MILLION) 48
TABLE 27 AMERICAS: CANNABIDIOL (CBD) MARKET, BY REGION 2019–2030 (USD MILLION) 49
TABLE 28 AMERICAS: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 49
TABLE 29 AMERICAS: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 50
TABLE 30 AMERICAS: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 50
TABLE 31 AMERICAS: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 50
TABLE 32 AMERICAS: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 51
TABLE 33 AMERICAS: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 51
TABLE 34 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY COUNTRY 2019–2030 (USD MILLION) 51
TABLE 35 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 51
TABLE 36 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 52
TABLE 37 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 52
TABLE 38 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 52
TABLE 39 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 53
TABLE 40 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 53
TABLE 41 US: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 53
TABLE 42 US: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 54
TABLE 43 US: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 54
TABLE 44 US: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 54
TABLE 45 US: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 55
TABLE 46 US: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 55
TABLE 47 CANADA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 55
TABLE 48 CANADA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 56
TABLE 49 CANADA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 56
TABLE 50 CANADA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 56
TABLE 51 CANADA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 57
TABLE 52 CANADA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 57
TABLE 53 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY COUNTRY 2019–2030 (USD MILLION) 57
TABLE 54 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 57
TABLE 55 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 58
TABLE 56 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 58
TABLE 57 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 58
TABLE 58 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 59
TABLE 59 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 59
TABLE 60 BRAZIL: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 59
TABLE 61 BRAZIL: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 60
TABLE 62 BRAZIL: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 60
TABLE 63 BRAZIL: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 60
TABLE 64 BRAZIL: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 61
TABLE 65 BRAZIL: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 61
TABLE 66 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 61
TABLE 67 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 62
TABLE 68 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 62
TABLE 69 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 62
TABLE 70 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 63
TABLE 71 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 63
TABLE 72 EUROPE: CANNABIDIOL (CBD) MARKET, BY REGION 2019–2030 (USD MILLION) 64
TABLE 73 EUROPE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 64
TABLE 74 EUROPE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 65
TABLE 75 EUROPE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 65
TABLE 76 EUROPE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 65
TABLE 77 EUROPE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 66
TABLE 78 EUROPE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 66
TABLE 79 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 66
TABLE 80 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 67
TABLE 81 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 67
TABLE 82 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 67
TABLE 83 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 68
TABLE 84 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 68
TABLE 85 FRANCE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 68
TABLE 86 FRANCE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 69
TABLE 87 FRANCE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 69
TABLE 88 FRANCE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 69
TABLE 89 FRANCE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 70
TABLE 90 FRANCE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 70
TABLE 91 ITALY: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 70
TABLE 92 ITALY: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 71
TABLE 93 ITALY: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 71
TABLE 94 ITALY: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 71
TABLE 95 ITALY: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 72
TABLE 96 ITALY: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 72
TABLE 97 GERMANY: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 72
TABLE 98 GERMANY: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 73
TABLE 99 GERMANY: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 73
TABLE 100 GERMANY: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 73
TABLE 101 GERMANY: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 74
TABLE 102 GERMANY: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 74
TABLE 103 UK: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 74
TABLE 104 UK: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 75
TABLE 105 UK: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 75
TABLE 106 UK: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 75
TABLE 107 UK: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 76
TABLE 108 UK: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 76
TABLE 109 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 76
TABLE 110 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 77
TABLE 111 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 77
TABLE 112 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 77
TABLE 113 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 78
TABLE 114 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 78
TABLE 115 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 78
TABLE 116 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 79
TABLE 117 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 79
TABLE 118 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 79
TABLE 119 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 80
TABLE 120 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 80
TABLE 121 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY REGION 2019–2030 (USD MILLION) 81
TABLE 122 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 81
TABLE 123 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 81
TABLE 124 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 82
TABLE 125 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 82
TABLE 126 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 82
TABLE 127 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 83
TABLE 128 JAPAN: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 83
TABLE 129 JAPAN: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 83
TABLE 130 JAPAN: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 84
TABLE 131 JAPAN: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 84
TABLE 132 JAPAN: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 84
TABLE 133 JAPAN: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 85
TABLE 134 CHINA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 85
TABLE 135 CHINA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 85
TABLE 136 CHINA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 86
TABLE 137 CHINA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 86
TABLE 138 CHINA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 86
TABLE 139 CHINA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 87
TABLE 140 INDIA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 87
TABLE 141 INDIA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 87
TABLE 142 INDIA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 88
TABLE 143 INDIA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 88
TABLE 144 INDIA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 88
TABLE 145 INDIA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 89
TABLE 146 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 89
TABLE 147 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 89
TABLE 148 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 90
TABLE 149 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 90
TABLE 150 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 90
TABLE 151 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 91
TABLE 152 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 91
TABLE 153 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 91
TABLE 154 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 92
TABLE 155 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 92
TABLE 156 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 92
TABLE 157 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 93

★調査レポート[世界のCBD（カンナビジオール）市場（〜2030年）] (コード：MRF23JUN003)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のCBD（カンナビジオール）市場（〜2030年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の産業用ヘンプ市場（～2030年）：製品別（繊維、シブ、種子）、種類別（ヘンプシードオイル、ヘンプシード、ヘンププロテイン、ヘンプエキス、カンナビジオール（CBD）ヘンプオイル、その他）、供給源別、農場別、用途別、地域別
  • ヘンプ入り炭酸飲料のグローバル市場2023年：カンナビジオール（CBD）、テトラヒドロカンナビノール（THC）
  • カンナビジオール（CBD）のグローバル市場（2023～2028）：マリファナ由来、ヘンプ由来
  • カンナビジオール（CBD）オイルのグローバル市場（2023～2028）：マリファナ由来、ヘンプ由来
  • 世界の医薬品用カンナビス市場予測2023-2029：ドロナビノール、ナビロン、ナビキシモールズ、カンナビジオール、その他
  • 世界の乳タンパク質市場（〜2030年）
  • 世界のウイルスワクチン市場（～2030年）：種類別（一価ワクチン、多価ワクチン）、形態別（液体、凍結乾燥）、容器形態別（バイアル、プレフィルドシリンジ）、バイオセーフティレベル別、技術別、疾患別、投与年齢別、投与経路別、エンドユーザー別、地域別
  • 世界の羊膜市場（〜2030年）

    • ◆H&Iグローバルリサーチのお客様（例）◆